• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Accenture joins Partnership on AI

Accenture joins Partnership on AI

October 20, 2017
CenterWatch Staff

Accenture has joined the Partnership on AI, an alliance of businesses, researchers, academics and policy makers that work to advance the understanding of artificial intelligence (AI) technology and develop best practices on the challenges and opportunities within the field. Accenture joins other prominent industry leaders who share its commitment to advancing the field of AI so that it benefits people and society. Accenture will actively contribute its own insights, research and capabilities in areas including Responsible AI, and will dedicate people and resources to collaborate with Partnership on AI members to help address important global challenges such as food, diversity, inclusion, health, education and economic opportunity.

“We are thrilled to join the Partnership on AI. We believe businesses, governments and academia have a critical role in co-innovating and applying AI to invent new educational, workforce and business models that are both responsible and responsive to the needs of people and society. It’s up to us to ensure AI can truly be a force for public good,” said Paul Daugherty, Accenture’s chief technology & innovation officer. “Our experience and research demonstrates that AI’s true potential can only be achieved by adopting a ‘people first’ approach that reflects what we call Responsible AI—being fair, accountable, honest, transparent and human-centric in how we apply AI. We are proud to join the Partnership on AI to contribute in these areas and help define a successful and impactful future for AI.”

“At Accenture, we understand the growth that AI can generate for businesses. Pioneering leaders are wielding it to reinvent how businesses innovate, operate, and compete,” said Nicola Morini, global lead for Accenture’s AI strategic growth initiative. “We are firmly committed to the Partnership on AI and its mission. Through our involvement, we will extend our current collaboration with our industry peers and ecosystem partners, and harness our combined thinking and talents to identify important areas for discussion and resolution, and formulate best practices to help AI achieve its potential to positively impact our world.”

Founded in 2016 to promote the belief that AI technologies hold great promise for raising the quality of people’s lives, the Partnership on AI and its members aim to recommend best practices and conduct and publish research under an open license in areas such as ethics, fairness and inclusivity; transparency, privacy, and interoperability; collaboration between people and AI systems; and the trustworthiness, reliability and robustness of the technology. Founding members include Apple, Amazon, Facebook, Google/DeepMind, IBM and Microsoft.

Accenture is dedicated to leading the charge toward Responsible AI, with the goal of providing better outcomes for all people. Working with its Global 2000 clients to actively design and direct AI to augment and amplify human capabilities, Accenture is committed to helping people to achieve more for themselves as individuals and for the world around them. Through its #AI4Good initiative, Accenture is making investments in unlocking the power of AI technologies through inclusive innovation co-created with ecosystem partners that leads to positive, scalable societal impact.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing